Efficacy of Blood Pressure-Lowering Pharmacotherapy in Isolated Diastolic Hypertension: A Systematic Synthesis of Evidence
Posted inCardiology Clinical Updates news

Efficacy of Blood Pressure-Lowering Pharmacotherapy in Isolated Diastolic Hypertension: A Systematic Synthesis of Evidence

This review synthesizes recent evidence, including a landmark 2026 meta-analysis, showing that blood pressure-lowering therapy provides similar cardiovascular benefits in patients with isolated diastolic hypertension compared to those with other hypertension phenotypes, even at low baseline diastolic levels.
TP53 Alterations Emerge as Critical Adverse Prognostic Factor in Pediatric and Young Adult Patients Treated with CD19-CAR T-Cell Therapy for Relapsed/Refractory B-ALL
Posted inHematology-Oncology news Pediatrics

TP53 Alterations Emerge as Critical Adverse Prognostic Factor in Pediatric and Young Adult Patients Treated with CD19-CAR T-Cell Therapy for Relapsed/Refractory B-ALL

A single-center retrospective study of 69 pediatric and young adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia reveals that TP53 alterations significantly compromise outcomes following tisagenlecleucel therapy. Patients harboring TP53 mutations or deletions demonstrated markedly lower remission rates and substantially worse event-free and overall survival compared to TP53 wild-type counterparts.
Blood Eosinophil Count at COPD Exacerbation Predicts Long-Term Cardiovascular Risk: A Retrospective Cohort Study
Posted inCardiology news Respiratory

Blood Eosinophil Count at COPD Exacerbation Predicts Long-Term Cardiovascular Risk: A Retrospective Cohort Study

A large retrospective cohort study of 143,517 patients reveals that non-eosinophilic acute exacerbations of COPD carry a significantly higher one-year risk of major adverse cardiovascular events compared with eosinophilic exacerbations, suggesting blood eosinophil count as a potential biomarker for cardiovascular risk stratification in COPD.
Robotic vs Laparoscopic Cholecystectomy: No Outcome Advantage Across Disease Severity Grades
Posted inGeneral Surgery news

Robotic vs Laparoscopic Cholecystectomy: No Outcome Advantage Across Disease Severity Grades

A retrospective study of 592 patients found equivalent outcomes between robotic and laparoscopic cholecystectomy regardless of acute cholecystitis severity. The only difference was slightly longer hospital stay in grade II-V patients undergoing laparoscopic surgery, though this was not an independent predictor of prolonged hospitalization.
Molecular Complexity of Endometrial Cancer: How Biomarker Patterns Vary Across Tumor Stages, Histology, and Molecular Subtypes
Posted innews OB/GYN & Women's Health Oncology

Molecular Complexity of Endometrial Cancer: How Biomarker Patterns Vary Across Tumor Stages, Histology, and Molecular Subtypes

A real-world study of 671 endometrial cancer patients reveals significant molecular heterogeneity. PTEN, ARID1A, and PIK3CA are the most prevalent biomarkers, while TP53 mutations and ERBB2 amplification cluster in advanced-stage and non-endometrioid tumors. The findings underscore the need for comprehensive molecular profiling to guide personalized treatment strategies.
Evidence Gaps in Maternity Guidelines: RCOG Green-Top Guidelines Show Limited Health Equity Considerations in High-Quality Recommendations
Posted innews OB/GYN & Women's Health

Evidence Gaps in Maternity Guidelines: RCOG Green-Top Guidelines Show Limited Health Equity Considerations in High-Quality Recommendations

A cross-sectional study of 37 RCOG Green-Top Guidelines reveals that 24% lack Grade A recommendations, while those with highest-level evidence show limited consideration of health equity and generalisability in supporting studies, highlighting critical gaps in guideline applicability.
Flash Glucose Monitoring Fails to Improve Glycemic Control but Reduces Large-for-Gestational-Age Risk in Gestational Diabetes
Posted inDiabetes & Endocrinology news OB/GYN & Women's Health

Flash Glucose Monitoring Fails to Improve Glycemic Control but Reduces Large-for-Gestational-Age Risk in Gestational Diabetes

A randomized trial of 205 pregnant women with gestational diabetes found that adjunctive flash glucose monitoring did not improve time-in-range glucose measurements compared to standard self-monitoring. However, the device was associated with significantly fewer large-for-gestational-age neonates, warranting further investigation in larger studies.